Effect of low dose allopurinol on glycemic control and glycemic variability in patients with type 2 diabetes mellitus: A cross-sectional study

BACKGROUND: Type 2 diabetes mellitus (DM), gout, and asymptomatic hyperuricemia are inter-connected pathologies. Glycemic control (GC), involving a range of treatments is central to the management of DM, whereas allopurinol continues to be the most widely recommended urate lowering agent. Allopurino...

Descripción completa

Detalles Bibliográficos
Autor principal: Alem, Manal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667255/
https://www.ncbi.nlm.nih.gov/pubmed/36406683
http://dx.doi.org/10.1016/j.heliyon.2022.e11549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667255/
https://www.ncbi.nlm.nih.gov/pubmed/36406683
http://dx.doi.org/10.1016/j.heliyon.2022.e11549

Ejemplares similares